Kreon (Pancreas Powder)

Pancreatin contains a mixture of pancreatic enzymes that break down carbohydrates, fats and proteins. The enteric coating protects the enzymes from stomach acid, allowing them to be released in the duodenum where they act on ingested nutrients. By supplementing the body’s own enzyme production, pancreatin restores normal digestion and improves absorption of nutrients.

The dosage of Kreon is individualized. A physician determines the appropriate number of capsules based on the patient’s weight, dietary fat intake, severity of enzyme deficiency and clinical response. Dosing is typically expressed in lipase units per meal and is adjusted to achieve optimal stool consistency and nutritional status.

Safety data for Kreon in pregnancy and lactation are limited. Because the product contains porcine‑derived enzymes, it should be used only if the potential benefit outweighs any possible risk to the fetus or infant. The prescribing clinician must evaluate the individual situation and discuss it with the patient.

To order Kreon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides a quotation, availability, shipping details (including any temperature requirements) and assistance with import documentation.

Kreon is a high‑potency pancreatin formulation with an enteric coating, similar to other pancreatic enzyme products such as Creon or Pancreaze. Compared with non‑coated preparations, Kreon’s coating improves enzyme delivery to the intestine and may provide more consistent symptom control. Choice of product often depends on physician preference, dosing convenience and patient tolerance.

Kreon capsules should be stored at temperatures below 25 °C in their original blister pack, protected from moisture and direct sunlight. Do not refrigerate or freeze the product. Keep the containers tightly closed and out of reach of children. If the capsules become damaged or discoloured, discard them.

Kreon is taken orally with each main meal and snack. The enteric‑coated capsules are swallowed whole with water; they should not be crushed, chewed or opened, as this would destroy the protective coating and reduce efficacy. The dose may be adjusted according to the fat content of the meal and the patient’s clinical response.

Serious adverse events, although rare, include severe allergic reactions such as anaphylaxis, intestinal obstruction, and exacerbation of pancreatitis. Patients should be instructed to seek immediate medical attention if they develop rash, swelling, difficulty breathing, intense abdominal pain or signs of bowel blockage. Prompt reporting of these events allows timely management.

Kreon is contraindicated in individuals with a known hypersensitivity to porcine proteins or any component of the formulation. It should also be avoided in patients with active intestinal obstruction or severe gastrointestinal disease where enzyme therapy would not be effective. Clinicians must review the patient’s medical history before prescribing.